Teva Pharmaceuticals, one of the biggest makers of generic drugs, has agreed to pay $85 million to settle a lawsuit over allegations the company contributed to Oklahoma's opioid painkiller epidemic
The settlement comes two months after Purdue Pharma, the maker of OxyContin, agreed to pay a $270 million settlement in the historic lawsuit, and just days before the scheduled start of a trial.The case against Johnson & Johnson, the only remaining defendant, will be heard by a district judge this week.
5 million of the settlement would be used to help establish a national addiction treatment and research center at Oklahoma State University, with additional payments of $15 million each year for the next five years beginning in 2020. The company will also provide $20 million of addiction treatment and opioid rescue medications to the center over the same five-year time frame.A remaining $12.5 million from the settlement will be used directly to help cities and counties with the opioid crisis.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Oklahoma reaches $85 million settlement with Teva Pharmaceuticals ahead of trialOklahoma has reached a $85 million settlement agreement with Israeli-based Teva ...
Consulte Mais informação »
Oklahoma, Teva Pharmaceuticals reach $85 million settlement in opioid caseThe Israel-based company admitted no wrongdoing and denies a role in the deadly crisis.
Consulte Mais informação »
Teva Pharm to pay Oklahoma $85 million to settle opioid claimsTeva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 mi...
Consulte Mais informação »
Teva Settles Oklahoma Opioid Case for $85 MillionTeva's $85 million settlement with Oklahoma comes days before the company was set to defend itself at a landmark trial amid some 2,000 lawsuits brought by states and local municipalities against pharmaceutical companies over the opioid crisis
Consulte Mais informação »
Oklahoma takes on drugmakers J&J, Teva in landmark opioid trialOklahoma’s $17 billion lawsuit against opioid makers Johnson & Johnson and Teva is the first to go to trial of more than 2,000 similar actions by state and local governments
Consulte Mais informação »
Can 'Aladdin' bring some magic to the Memorial Day box office?'Aladdin' is expected to make $75 million to $85 million at the North American box office over the four-day weekend, Disney says. That total should easily put the live-action reboot of the 1992 animated hit in the top spot at the Memorial Day box office
Consulte Mais informação »
IN-DEPTH Q&A: The cofounder of GroupMe — a text-messaging platform that sold for $85 million a year after launch — has raised $107 million for a startup that's revolutionizing how music gets made. Here are his lessons for pitching, leading, and building a company.GroupMe and Blade cofounder Steve Martocci is now CEO of the platform Splice, which recently raised $57.5 million in its Series C funding round.
Consulte Mais informação »
Teva Pharm to pay Oklahoma $85 million to settle opioid claimsTeva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 mi...
Consulte Mais informação »
Teva Settles Oklahoma Opioid Case for $85 MillionTeva's $85 million settlement with Oklahoma comes days before the company was set to defend itself at a landmark trial amid some 2,000 lawsuits brought by states and local municipalities against pharmaceutical companies over the opioid crisis
Consulte Mais informação »
Oklahoma, Teva Pharmaceuticals reach $85 million settlement in opioid caseThe Israel-based company admitted no wrongdoing and denies a role in the deadly crisis.
Consulte Mais informação »
Oklahoma reaches $85 million settlement with Teva Pharmaceuticals ahead of trialOklahoma has reached a $85 million settlement agreement with Israeli-based Teva ...
Consulte Mais informação »